Ponencia
Transcriptional programs of monocyte-derived tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects obtained by modulation with dexamethasone and monophosphoryl lipid A.
Fecha
2016Institución
Resumen
Objective: Our
aim
was
to
study
the
gene
expression
paNern
of
monocyte-‐derived
tolerogenic
DCs
(tolDCs)
obtained
through
modulaUon
with
dexamethasone
and
monophosphoryl
lipid
A
(MPLA-‐tDCs)
in
order
to
idenUfy
molecular
regulators
and
pathways
that
det